GEN Exclusives

More »

GEN News Highlights

More »
Aug 24, 2007

Averion Expands CRO Services into Brazil

  • Averion and Biocancer, two clinical research organizations (CROs), will jointly market and contract complementary services to biotechnology, pharmaceutical, and medical device companies.

    Biocancer is based in Brazil and focuses on oncology. “This agreement expands our reach to South America, providing us with access to leading clinical sites and large patient populations,” points out Philip Lavin, Ph.D., Averion's CEO. “We plan to continue building on our international oncology CRO offering through strategic partnerships and acquisitions.”



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?